If you have trouble leaving a comment, review this help page. Still having problems? Let us know. If you find yourself moderated, take a moment to review our comment policy.
Monday marks Manhattan Beach Mayor David Lesser's monthly Walk 'N' Talk event starting at 8 a.m. at Peet's Coffee and Tea, 328 Manhattan Beach Blvd.
Anyone interested in talking with Lesser can join in a walk along The Strand. It should range from 60 to 90 minutes and will be rescheduled in the event of rain.
Former Mayors Nick Tell and Wayne Powell also held walks to connect with residents.
Reputation: Words written: Words per post: Joined: Last visit: Location: Website:
With each full moon there is a curse, some curses that can't be broken.
Owner:
Game Masters:
This topic is an Out Of Character part of the roleplay, ?Full Moon Rising?. Anything posted here will also show up there.
Topic Tags:
Forum for completely Out of Character (OOC) discussion, based around whatever is happening In Character (IC). Discuss plans, storylines, and events; Recruit for your roleplaying game, or find a GM for your playergroup.
First post: ? 1 post ? Page 1 of 1
This is the auto-generated OOC topic for the roleplay "Full Moon Rising"
You may edit this first post as you see fit.
Ville.Sunfall
Member for 0 years
First post: ? 1 post ? Page 1 of 1
Post a reply
RolePlayGateway is a site built by a couple roleplayers who wanted to give a little something back to the roleplay community. The site has no intention of earning any profit, and is paid for out of their own pockets.
If you appreciate what they do, feel free to donate your spare change to help feed them on the weekends. After selecting the amount you want to donate from the menu, you can continue by clicking on PayPal logo.
Our Sponsors
RolePlayGateway is proudly powered by obscene amounts of caffeine, duct tape, and support from people like you. It operates under a "don't like it, suggest an improvement" platform, and we gladly take suggestions for improvements or changes.
The custom-built "roleplay" system was designed and implemented by Eric Martindale as of July 2009. All attempts to replicate or otherwise emulate this system and its method of organizing roleplay are strictly prohibited without his express written and contractual permission; violators will be prosecuted to the fullest extent of the law.
? RolePlayGateway, LLC | with the support of LocalSense
I am currently working on a turn based style game-similar to the way words with friends works. I was planning on using a database service such as Parse or Stack mob. However I have recently been looking into Game center and Google's Game Services.
What are some of the benefits of using a database as a service such as parse or stack mob over using Game Center or Google Play's Game Services.
By: Angela Ayles on Thursday, August 1st, 2013 @ 2:33 pm?
Breast cancer is the most commonly diagnosed cancer among women in the United States?with one in every 8 women developing this cancer. Breast cancer typically develops as a small tumor (or lump) in the tissues throughout the breasts and then, if cancerous, spreads through the lymph nodes.
The best hope of surviving a breast cancer diagnosis is via early detection. That?s why routine self-exams of the breasts to identify any lumps, as well as annual check-ups and mammograms with your health care professional are important.
Here are 10 early warning signs to look out for during your self-breast exams at home?
1. Detection of a Lump
When performing a self breast exam, carefully apply pressures to the breasts and surrounding tissues with your fingers. Both benign (non cancerous) and malignant (cancerous) breast lumps sometimes form under the armpit, in the collarbone, near the site of the lymph nodes, and around the nipples, as rigid, hard, tender lumps that don?t move when you press against them. Any tenderness may be due to swollen tissues. If you detect a lump, call your doctor immediately.
Just a few weeks ago, Apple found itself on the wrong side of a decision when US District Judge Denise Cote ruled that Apple had, in fact, conspired with book publishers to raise the price of e-books across the industry.
Today, the DOJ announced a proposed remedy for Apple's alleged wrongdoing. The remedy aims to stop Apple's "illegal activities" and restore competition to the e-book marketplace.
As laid out by the DOJ, the proposed remedy not only requires Apple to put an end to its existing agency-model contracts with book publishers, but also precludes Apple from entering into "new e-book distribution contracts which would restrain Apple from competing on price."
The DOJ writes:
Under the department's proposed remedy, Apple will be prohibited from again serving as a conduit of information among the conspiring publishers or from retaliating against publishers for refusing to sell e-books on agency terms. Apple will also be prohibited from entering into agreements with suppliers of e-books, music, movies, television shows or other content that are likely to increase the prices at which Apple's competitor retailers may sell that content. To reset competition to the conditions that existed before the conspiracy, Apple must also for two years allow other e-book retailers like Amazon and Barnes & Noble to provide links from their e-book apps to their e-bookstores, allowing consumers who purchase and read e-books on their iPads and iPhones easily to compare Apple's prices with those of its competitors.
That certainly seems heavy handed.
The DOJ also recommends that Apple be appointed an external monitor by the court who will ensure that the company doesn't run afoul of any antitrust laws going forward. And as if that weren't enough, the monitor's salary and expenses will, according to the proposal, be paid for by Apple.
Think the DOJ is done?
Not quite.
The DOJ also recommends that Apple hire an internal antitrust compliance officer who will not only ensure that Apple complies with court imposed remedies, but will also be tasked with training and educating Apple's senior executives and employees about pertinent antitrust laws.
We all know stars undergo major transformations by a team of makeup artists to look gorgeous. But what do these stars look like without their “face” on? We’ve compiled a gallery of today’s major celebrities to see what they look like au naturel. Some actually look decent without being made up, while others are pretty ...
DUBAI (Reuters) - Two days before his inauguration as Iran's new president, Hassan Rouhani said on Friday that Israeli occupation of Palestinian land had inflicted a "wound" on the Muslim world, according to a segment of his remarks broadcast on Iran's state-run Press TV.
An earlier report by Iran's student news agency ISNA had quoted Rouhani as saying: "The Zionist regime is a wound that has sat on the body of the Muslim world for years and needs to be removed."
That version echoed the fiercely anti-Israeli language of outgoing President Mahmoud Ahmadinejad, but was swiftly repudiated by Iranian state media, which said unidentified news agencies had distorted Rouhani's remarks.
Press TV then broadcast an excerpt from an exchange between Rouhani and journalists at a rally to mark Iran's annual Al Qods Day in support of the Palestinians.
"After all, in our region there's been a wound for years on the body of the Muslim world under the shadow of the occupation of the holy land of Palestine and the beloved al-Qods (Jerusalem)," Rouhani said in the segment.
Israeli Prime Minister Benjamin Netanyahu seized on ISNA's version of Rouhani's comments, saying they showed the reputedly moderate Iranian cleric was as hostile to Israel as Ahmadinejad, whose denial of the Holocaust and description of Israel as a "cancerous tumor" prompted international condemnation.
The United States and its allies suspect Iran of seeking a nuclear weapons capability. Tehran says its nuclear program is purely for peaceful purposes, but Israel regards it as a threat to its existence and refuses to rule out military action.
With a more pragmatic president in Iran, Western countries may see a better chance for diplomacy to lead to a deal to curb Tehran's uranium enrichment program and avoid any conflict.
"The true face of Rouhani has been revealed sooner than expected. Even if they hurry to deny his words - this is what the man thinks and this is the Iranian regime's plan of action," Netanyahu said in a statement.
Rouhani's words "must awaken the world from the illusion in which part of it is placed since the Iranian elections", he declared, saying Iran still aimed "to acquire nuclear weapons in order to threaten Israel, the Middle East and world peace".
"A nation that threatens to destroy the state of Israel must not be allowed to have weapons of mass destruction," he said.
Ahmadinejad addressed Israel on Qods Day in his last speech as president. "You planted wind in our region and you will reap the storm. I swear to God that a ferocious storm is coming and it will uproot the Zionist entity," Iran's state news agency IRNA quoted him as saying.
(Reporting by Marcus George in Dubai and Ori Lewis in Jerusalem; writing by Alistair Lyon; editing by Jon Boyle)
[unable to retrieve full-text content]Lasrick writes "At the Dot Earth blog in the NY Times, 'Big companies have many, and sometimes conflicting, interests, as a spokesperson for Google tried to explain to the environmental blogger Brian Merchant this way: “[W]hile we disagree on climate change policy, we share an interest with Senator Inhofe in the employees and data center we have in Oklahoma.” Now the Web giant is facing fresh criticism, this time in an open letter from 17 scientists and policy researchers who were invited to Google’s Silicon Valley headquarters back in 2011 to explore ways to improve climate science communication....'"
New partnership strengthens global research efforts
Beijing, China/Rockville, MD, USAAugust 2, 2013 With the global tuberculosis epidemic becoming more deadly, costly, and difficult to treat, Chinese Center for Disease Control and Prevention (China CDC) and Aeras today signed a memorandum of understanding to advance research and development of new tuberculosis vaccines. An improved TB vaccine offers the best hope for eliminating this airborne infectious disease that kills 1.4 million people worldwide each year.
While China has achieved significant reductions in TB illness and death over the past 30 years, TB remains a major public threat, with over one million new cases in China each year. A study published in the New England Journal of Medicine last year found that one in 10 cases of TB in China are resistant to the most commonly-used drugs. Based on the World Health Organization's estimates of global multidrug-resistant TB (MDR-TB), China has the highest annual number of cases of MDR-TB in the worlda quarter of the cases worldwide.
The new collaboration between China CDC and Aeras will accelerate research efforts for new vaccines by supporting studies that determine the incidence of TB infection, and will aim to strengthen the capacity within China to conduct future vaccine clinical trials.
"Innovation is the key to controlling and ultimately eliminating this disease," said Dr. Wang Yu, China CDC Director General. "And we have embraced innovation in our TB control efforts in China. We have adopted the latest technologies to diagnose TB. We have advanced innovative approaches to address TB and drug-resistant TB, and to promote the research that is necessary to urgently develop needed new tools to prevent, diagnose and treat it. We have made TB a high priority on our public health agenda, and will continue to seek out new and better ways to prevent and treat TB in communities across our country. But we know that this will not be enough. We will not defeat TB in our country or in the world without new, more effective vaccines. There is a coordinated, global effort underway to develop these urgently needed vaccines, and China must be a partner in this endeavor. With that goal in mind, we are excited to announce a new collaboration with Aeras to advance the research and development of new, more effective vaccines."
China CDC is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of services. Aeras is a nonprofit biotech based in Maryland, USA and Cape Town, South Africa, with the mission of advancing tuberculosis vaccines for the world. The meeting also marks the official opening by Aeras of an office in Beijing to facilitate and strengthen collaboration with Chinese researchers, partnerships that will be critical for developing tuberculosis vaccines for China and the world. Aeras supports half of the vaccine candidates currently in clinical trials, along with a portfolio of earlier stage candidates.
TB vaccine research and development requires dedicated investment and broad support to address scientific complexities and costs. No one organization or institution can do it alone, therefore global partnerships between individuals, research organizations, academic institutions, funders, policy-makers, and others are essential to advance TB vaccine science.
"Collaboration with Chinese researchers is crucial if we are going to defeat this global infectious disease killer," said Tom Evans, president & CEO of Aeras. "China has the technical expertise, resources and desire to develop effective vaccines against TB. Because of the high incidence of TB, the technical expertise, and a vaccine development infrastructure, China is perfectly poised to be at the forefront of global prevention efforts."
The global TB epidemic requires novel approaches, new tools and sufficient resources to mitigate what is now a more challenging and expensive disease to control than when the World Health Organization declared it a global emergency more than 20 years ago. The emergence of MDR-TB, now found in all countries surveyed worldwide, is confounding global efforts to halt the spread of TB and is putting an enormous economic burden on health systems globally. Alarmingly, new genetic research suggests that the bacterium could be poised to emerge stronger and more deadly than ever before, making it especially well-suited to spreading disease in a highly mobile and densely populated world.
"The ultimate game-changer in the battle to eliminate TB would be an improved vaccine that prevents children and adults from developing and transmitting disease," added Evans. The MOU was signed today during a meeting of global TB experts from the World Health Organization and other global leaders in TB research.
Tuberculosis is the world's second deadliest infectious disease, with 8.7 million new cases in 2011. Current guidelines require a minimum of six to nine months of treatment. TB is changing and evolving, making new vaccines more crucial for controlling the epidemic. Tuberculosis is the leading cause of death for people living with HIV/AIDS. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are hampering treatment and control efforts by making the disease more difficult to treat.
About Chinese Center for Disease Control and Prevention
Chinese Center for Disease Control and Prevention (China CDC) is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of service. China CDC is committed to strengthening research on strategies and measures for disease control and prevention. China CDC organizes and implements control and prevention plans for different kinds of diseases; carries out public health management for food safety, occupational health, health related product safety, radiation health, environmental health, health care for women and children, among others; conducts applied scientific research; provides technical guidance, staff training and quality control for disease control and prevention and public health services throughout the country; and acts as a national working group for diseases prevention, emergency relief, and construction of public health information systems.
About Aeras
Aeras is a global nonprofit biotech advancing TB vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras is based in Rockville, Maryland, Cape Town, South Africa, and Beijing, China.
For more information, visit http://www.aeras.org
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Chinese CDC and Aeras sign agreement to collaborate on TB vaccine R&DPublic release date: 2-Aug-2013 [ | E-mail | Share ]
New partnership strengthens global research efforts
Beijing, China/Rockville, MD, USAAugust 2, 2013 With the global tuberculosis epidemic becoming more deadly, costly, and difficult to treat, Chinese Center for Disease Control and Prevention (China CDC) and Aeras today signed a memorandum of understanding to advance research and development of new tuberculosis vaccines. An improved TB vaccine offers the best hope for eliminating this airborne infectious disease that kills 1.4 million people worldwide each year.
While China has achieved significant reductions in TB illness and death over the past 30 years, TB remains a major public threat, with over one million new cases in China each year. A study published in the New England Journal of Medicine last year found that one in 10 cases of TB in China are resistant to the most commonly-used drugs. Based on the World Health Organization's estimates of global multidrug-resistant TB (MDR-TB), China has the highest annual number of cases of MDR-TB in the worlda quarter of the cases worldwide.
The new collaboration between China CDC and Aeras will accelerate research efforts for new vaccines by supporting studies that determine the incidence of TB infection, and will aim to strengthen the capacity within China to conduct future vaccine clinical trials.
"Innovation is the key to controlling and ultimately eliminating this disease," said Dr. Wang Yu, China CDC Director General. "And we have embraced innovation in our TB control efforts in China. We have adopted the latest technologies to diagnose TB. We have advanced innovative approaches to address TB and drug-resistant TB, and to promote the research that is necessary to urgently develop needed new tools to prevent, diagnose and treat it. We have made TB a high priority on our public health agenda, and will continue to seek out new and better ways to prevent and treat TB in communities across our country. But we know that this will not be enough. We will not defeat TB in our country or in the world without new, more effective vaccines. There is a coordinated, global effort underway to develop these urgently needed vaccines, and China must be a partner in this endeavor. With that goal in mind, we are excited to announce a new collaboration with Aeras to advance the research and development of new, more effective vaccines."
China CDC is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of services. Aeras is a nonprofit biotech based in Maryland, USA and Cape Town, South Africa, with the mission of advancing tuberculosis vaccines for the world. The meeting also marks the official opening by Aeras of an office in Beijing to facilitate and strengthen collaboration with Chinese researchers, partnerships that will be critical for developing tuberculosis vaccines for China and the world. Aeras supports half of the vaccine candidates currently in clinical trials, along with a portfolio of earlier stage candidates.
TB vaccine research and development requires dedicated investment and broad support to address scientific complexities and costs. No one organization or institution can do it alone, therefore global partnerships between individuals, research organizations, academic institutions, funders, policy-makers, and others are essential to advance TB vaccine science.
"Collaboration with Chinese researchers is crucial if we are going to defeat this global infectious disease killer," said Tom Evans, president & CEO of Aeras. "China has the technical expertise, resources and desire to develop effective vaccines against TB. Because of the high incidence of TB, the technical expertise, and a vaccine development infrastructure, China is perfectly poised to be at the forefront of global prevention efforts."
The global TB epidemic requires novel approaches, new tools and sufficient resources to mitigate what is now a more challenging and expensive disease to control than when the World Health Organization declared it a global emergency more than 20 years ago. The emergence of MDR-TB, now found in all countries surveyed worldwide, is confounding global efforts to halt the spread of TB and is putting an enormous economic burden on health systems globally. Alarmingly, new genetic research suggests that the bacterium could be poised to emerge stronger and more deadly than ever before, making it especially well-suited to spreading disease in a highly mobile and densely populated world.
"The ultimate game-changer in the battle to eliminate TB would be an improved vaccine that prevents children and adults from developing and transmitting disease," added Evans. The MOU was signed today during a meeting of global TB experts from the World Health Organization and other global leaders in TB research.
Tuberculosis is the world's second deadliest infectious disease, with 8.7 million new cases in 2011. Current guidelines require a minimum of six to nine months of treatment. TB is changing and evolving, making new vaccines more crucial for controlling the epidemic. Tuberculosis is the leading cause of death for people living with HIV/AIDS. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are hampering treatment and control efforts by making the disease more difficult to treat.
About Chinese Center for Disease Control and Prevention
Chinese Center for Disease Control and Prevention (China CDC) is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of service. China CDC is committed to strengthening research on strategies and measures for disease control and prevention. China CDC organizes and implements control and prevention plans for different kinds of diseases; carries out public health management for food safety, occupational health, health related product safety, radiation health, environmental health, health care for women and children, among others; conducts applied scientific research; provides technical guidance, staff training and quality control for disease control and prevention and public health services throughout the country; and acts as a national working group for diseases prevention, emergency relief, and construction of public health information systems.
About Aeras
Aeras is a global nonprofit biotech advancing TB vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras is based in Rockville, Maryland, Cape Town, South Africa, and Beijing, China.
For more information, visit http://www.aeras.org
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Eternicom
We all know stars undergo major transformations by a team of makeup artists to look gorgeous. But what do these stars look like without their “face” on? We’ve compiled a gallery of today’s major celebrities to see what they look like au naturel. Some actually look decent without being made up, while others are pretty ...
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sFkzxn65WLod8tiKjiwP8ORfxIdYjEj7vCt0N_RLbhjTSSSDji8GRwLdzdoKZSz_ErQIev4DDUoiZdbNg9ONnwExUj_O-7CAHmpkWDIxc=s0-d){kind=small}
Public release date: 2-Aug-2013
Share ]